These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35573731)

  • 1. Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort.
    Jia C; Ma Y; Wang M; Liu W; Tang F; Chen J
    Front Mol Biosci; 2022; 9():844721. PubMed ID: 35573731
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
    Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
    Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types.
    Dai L; Guo X; Xing Z; Tao Y; Liang W; Shi Z; Hu W; Zhou S; Wang X
    BMC Cancer; 2023 Jan; 23(1):102. PubMed ID: 36717836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC02257, an Enhancer RNA of Prognostic Value in Colon Adenocarcinoma, Correlates With Multi-Omics Immunotherapy-Related Analysis in 33 Cancers.
    Xiao J; Liu Y; Yi J; Liu X
    Front Mol Biosci; 2021; 8():646786. PubMed ID: 33996902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activating protein 1 transcription factor basic leucine zipper transcription factor, ATF-like (BATF), regulates lymphocyte- and mast cell-driven immune responses in the setting of allergic asthma.
    Übel C; Sopel N; Graser A; Hildner K; Reinhardt C; Zimmermann T; Rieker RJ; Maier A; Neurath MF; Murphy KM; Finotto S
    J Allergy Clin Immunol; 2014 Jan; 133(1):198-206.e1-9. PubMed ID: 24290279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma.
    Wang Z; Zheng W; Chen Z; Wu S; Chang H; Cai M; Cai H
    Front Oncol; 2022; 12():1055376. PubMed ID: 36531056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells.
    Zhang X; Zhang C; Qiao M; Cheng C; Tang N; Lu S; Sun W; Xu B; Cao Y; Wei X; Wang Y; Han W; Wang H
    Cancer Cell; 2022 Nov; 40(11):1407-1422.e7. PubMed ID: 36240777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-cancer analysis of
    Jia B; Liu J; Hu X; Xia L; Han Y
    Ann Transl Med; 2022 Dec; 10(24):1355. PubMed ID: 36660720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of G-protein-signaling modulator 2 as a prognostic and diagnostic marker for pan-cancer.
    Hu LM; Ou XH; Shi SY
    Front Genet; 2022; 13():984714. PubMed ID: 36186420
    [No Abstract]   [Full Text] [Related]  

  • 13. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.
    Ding JT; Yu XT; He JH; Chen DZ; Guo F
    Front Genet; 2022; 13():912003. PubMed ID: 35783266
    [No Abstract]   [Full Text] [Related]  

  • 15. Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers.
    Gong L; Zhong M; Gong K; Wang Z; Zhong Y; Jin Y; Chen H; Tai P; Chen X; Chen A; Cao K
    J Inflamm Res; 2023; 16():2297-2315. PubMed ID: 37273485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.
    Chen Y; Wen H; Li Y; Han Y; Tan J; Guo C; Cai C; Liu P; Peng Y; Liu Y; Wang X; Zeng S; Feng Z; Shen H
    Biol Proced Online; 2023 Jun; 25(1):16. PubMed ID: 37268895
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Luo W; Wang J; Dai X; Zhang H; Qu Y; Xiao W; Ye D; Zhu Y
    Front Oncol; 2021; 11():754845. PubMed ID: 34868963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
    Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity.
    Chen F; Fan Y; Liu X; Zhang J; Shang Y; Zhang B; Liu B; Hou J; Cao P; Tan K
    Front Mol Biosci; 2021; 8():789703. PubMed ID: 35087869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.